BAP1 status in PM histologic examination can inform diagnosis, prognosis, and possibily cancer prevention in those patients with hereditary BAP1 mutations, and it is a main focus of clinical research for personalized treatments [8,9]. This evidence concerns the gene BAP1 and cancer.